CS Analytical Expands Pharmaceutical Raw Material and Finished Product Testing with the Launch of RM Analytical

Core Insights - CS Analytical (CSA) has launched Raw Material Analytical (RMA), expanding its testing capabilities for raw materials and finished products in the pharmaceutical and biopharmaceutical industries, positioning itself as a comprehensive analytical partner for manufacturers [1] Group 1: Expansion of Services - The new service launch enhances CSA's ability to perform testing in compliance with major compendial standards, including USP, EP, JP, BP, ChP, and ACS [1] - CSA is prepared to support increased testing volumes while maintaining high levels of scientific rigor, data integrity, and regulatory compliance [1] Group 2: Team and Infrastructure - CSA's team consists of experienced scientists with advanced degrees in chemistry and extensive industry expertise, operating with enhanced laboratory infrastructure and advanced instrumentation [1] - The service enhancements are designed to deliver faster turnaround times without compromising accuracy or reliability [1] Group 3: Client Commitment - The expanded testing portfolio allows CSA to support both routine and specialized testing, including non-compendial and client-specific methods for raw materials and finished products [1] - CSA emphasizes the importance of precise, timely analytical data for ensuring product quality, safety, and regulatory compliance, reflecting its commitment to raising the bar for analytical excellence [1] Group 4: Company Background - CS Analytical is the only FDA-regulated, cGMP laboratory dedicated exclusively to drug and medical device container and package qualification testing [1] - RMA is committed to delivering high standards of accuracy, reliability, and compliance across the entire product lifecycle, from incoming raw materials to finished products and packaging systems [1]